SAN DIEGO, Calif., May 23, 2013 — KFx Medical Corporation announced that it received Notice of Allowance of claims for is application entitled: SYSTEM AND METHOD FOR ATTACHING SOFT TISSUE TO BONE used in knotless double row rotator cuff repair.
“We are thrilled to be able to announce this additional allowance for a total of three reported this week. Once issued these new patents will bring us to 11 issued U.S. patents, 7 pending U.S. applications, 3 issued foreign patents, and 3 pending foreign applications. Patents are clearly a core competency for our organization. Malcolm Heaven, our VP of R&D and his team are extraordinarily inventive. Combine them with our legal team of Knobbe, Martens, Olson and Bear LLP and you can see the exceptional results. We will continue to pursue the protection of our inventions including litigation where necessary against infringers,” indicated Tate Scott, president and CEO.
On August 1, 2011, KFx filed a complaint against Arthrex alleging claims of induced and contributory infringement of United States Patent Number 7,585,311. Since that time KFx has been awarded an additional three surgical method patents covering knotless double row repair, two of which were added to the suit versus Arthrex (United States Patent Numbers 8,100,942 and 8,109,969). In October 2012 KFx Medical Corporation announced that the United States District Court ruled all 6 of the 6 disputed claims in favor of KFx in the Markman Hearing. Presently the case is scheduled to be heard in August 2013 in San Diego.
The new AppianFx line of implants from KFx reattach tissue to bone in shoulder, knee, foot and ankle procedures which combined exceed well over 1 million annual surgical procedures in the United States. Product offerings include those that directly place and secure tissue into bone both with and without the use of sutures.
About KFx Medical
Headquartered in Carlsbad, Calif., KFx Medical Corporation was founded in 2003 to develop products for tissue fixation in a variety of orthopedic surgical procedures performed on the shoulder, knee, foot, and ankle. KFx provides simple systems for orthopedic surgeons focused on sports medicine. The new AppianFx line of implants from KFx reattach tissue to and in bone in shoulder, knee, foot and ankle procedures which combined exceed well over 1 million annual surgical procedures in the United States. Product offerings include those that directly place and secure tissue into bone both with and without the use of sutures.
The company is privately held — Investors include Alloy Ventures, Charter Life Sciences, Arboretum Ventures, Montreux Equity Partners, and MB Venture Partners.
KFx Medical Corporation
Tate Scott, 760-444-8820
President & CEO